معرفی
Mats Larhed is a Professor in the Department of Medicinal Chemistry at Uppsala University, where he also serves as Vice-Rector for Medicine and Pharmacy since 2020. His academic journey began with a Master of Science in Pharmacy in 1991, followed by appointments as Professor in Combinatorial Chemistry in 2007 and Professor in Medicinal Chemistry in 2015.
Dr. Larhed's research spans multiple areas of medicinal chemistry with particular expertise in:
- Design and synthesis of IRAP (Insulin-Regulated Aminopeptidase) inhibitors
- Angiotensin receptor ligands, particularly AT2 receptor research
- Application of microwave chemistry and flow chemistry techniques in drug discovery
- Development of novel synthetic methodologies for pharmaceutical compounds
- Drug discovery for idiopathic pulmonary fibrosis (IPF)
Analysis of his recent publications (2020-2024) reveals a strong focus on neurocognitive effects of IRAP inhibitors, structural optimization of angiotensin receptor ligands, and high-throughput screening approaches for drug discovery. His work bridges synthetic chemistry with biological evaluation across multiple disease areas including pulmonary fibrosis, cognitive disorders, and cancer imaging, with significant contributions to understanding the structural basis of enzyme inhibition and developing novel therapeutic approaches.
Dr. Larhed leads research groups focusing on preparative medicinal chemistry, with expertise in microwave-assisted synthesis, flow chemistry, and the development of novel synthetic methodologies for pharmaceutical applications. His laboratory has produced numerous publications in high-impact journals including International Journal of Molecular Sciences, European Journal of Medicinal Chemistry, and Journal of Organic Chemistry.
As Vice-Rector for Medicine and Pharmacy, Dr. Larhed plays a significant administrative role at Uppsala University, overseeing academic and research activities in these fields. His dual role as both an active researcher and senior administrator demonstrates his standing within the academic community and his commitment to advancing pharmaceutical sciences.
